organization · Reporting owner
Aimei Investment Ltd
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aimei Health Technology Co., Ltd.AFJK · Entity 7334 | 10% owner | December 01, 2023 | December 05, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aimei Health Technology Co., Ltd.
Report date December 01, 2023 · Filed December 05, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 1,905,000 |
Reported balance
After 2023-12-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-12-01 · Purchase · Acquired 332,000 · Balance 1,905,000 F1: Represents shares held by our sponsor Aimei Investment Ltd.. Ms. Huang Han has voting and dispositive power over the shares held of record by our sponsor. Ms. Huang Han disclaims any beneficial ownership of the shares held by our sponsor, except to the extent of her pecuniary interest therein. |
| RightsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 332,000 |
Reported balance
After 2023-12-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-12-01 · Purchase · Acquired 332,000 · Balance 332,000 F4: The reporting person acquired units, consisting of shares and rights. F3: One right automatically converts into one-fifth (1/5) of one ordinary share upon the consummation of the registrant's initial business combination, as described in the registrant's prospectus filed with the SEC. F2: Represents rights held by our sponsor Aimei Investment Ltd.. Ms. Huang Han has voting and dispositive power over the rights held of record by our sponsor. Ms. Huang Han disclaims any beneficial ownership of the rights held by our sponsor, except to the extent of her pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares held by our sponsor Aimei Investment Ltd.. Ms. Huang Han has voting and dispositive power over the shares held of record by our sponsor. Ms. Huang Han disclaims any beneficial ownership of the shares held by our sponsor, except to the extent of her pecuniary interest therein.
F2: Represents rights held by our sponsor Aimei Investment Ltd.. Ms. Huang Han has voting and dispositive power over the rights held of record by our sponsor. Ms. Huang Han disclaims any beneficial ownership of the rights held by our sponsor, except to the extent of her pecuniary interest therein.
F3: One right automatically converts into one-fifth (1/5) of one ordinary share upon the consummation of the registrant's initial business combination, as described in the registrant's prospectus filed with the SEC.
F4: The reporting person acquired units, consisting of shares and rights.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2023 Filed Dec 5, 2023 16:37 UTC | Aimei Health Technology Co., Ltd. AFJK · Entity 7334 | PurchaseRights · Derivative | 332,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-043708 · ownership.xml · derivative · entry 2 Aimei Investment Ltd · CIK 0002002807 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,000 Underlying: Ordinary shares · Not disclosed shares Expires not disclosed F4 · price: The reporting person acquired units, consisting of shares and rights. F3 · derivative.exercise_date: One right automatically converts into one-fifth (1/5) of one ordinary share upon the consummation of the registrant's initial business combination, as described in the registrant's prospectus filed with the SEC. F3 · derivative.expiration_date: One right automatically converts into one-fifth (1/5) of one ordinary share upon the consummation of the registrant's initial business combination, as described in the registrant's prospectus filed with the SEC. F3 · derivative.underlying_shares: One right automatically converts into one-fifth (1/5) of one ordinary share upon the consummation of the registrant's initial business combination, as described in the registrant's prospectus filed with the SEC. F2 · ownership.direct: Represents rights held by our sponsor Aimei Investment Ltd.. Ms. Huang Han has voting and dispositive power over the rights held of record by our sponsor. Ms. Huang Han disclaims any beneficial ownership of the rights held by our sponsor, except to the extent of her pecuniary interest therein. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 16:37 UTC | Aimei Health Technology Co., Ltd. AFJK · Entity 7334 | PurchaseOrdinary Shares | 332,000 | $10.00 | $3,320,000.00 |
DisclosureSEC source: 0001493152-23-043708 · ownership.xml · nonDerivative · entry 1 Aimei Investment Ltd · CIK 0002002807 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,905,000 F1 · ownership.direct: Represents shares held by our sponsor Aimei Investment Ltd.. Ms. Huang Han has voting and dispositive power over the shares held of record by our sponsor. Ms. Huang Han disclaims any beneficial ownership of the shares held by our sponsor, except to the extent of her pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.